Create Medic Co., Ltd. engages in the research, manufacture, and sale of medical appliances in Japan and internationally. It offers urology products, such as all silicone foley and clinical antibacterial foley catheters, all silicone foley tray kits, clinie antibacterial foley tray kits, clinie urine collection bags, clean leg bags, safety cat products, safety cat fast casts, RUSCH flow cast quick products, and RUSCH tumor ureteral stents; and gastroenterology products, including ileus tubes, hydrophilic ileus tubes, first finger products, clinie ENBD tubes, balloon sonde products, EV tubes, endoscopic guidewire products, and esophageal dilation balloon catheters. The company also provides PEG products, such as percutaneous endoscopic gastronomy (PEG) kits with loop fixture, CLINY introducer PEG kits, PEG kit bumper type products, loop fixture II products, all silicone gastronomy balloon catheters for replacement, balloon button sets, gastronomy button sets, gastronomy replacement catheter sets, and all silicone PEG J catheters. In addition, it offers surgery products comprising clinie PTCD kits, PTCD kits, bio mariner II products, MIT Force 3mm and 3mm trocar products, MIT arm handpieces, MIT arm disposable tips, and MIT drains; anesthesia/respiratory system products, such as double lumen endotracheal, tracheostomy, CLINI tracheostomy, and clinie tracheostomy tubes, as well as clini trachiguard and accufuser products; and biopsy-related products, which include automatic biopsy needle acecut and surecut suction biopsy needle. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. Create Medic Co., Ltd. was incorporated in 1974 and is headquartered in Yokohama, Japan.
Metrics to compare | 5187 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship5187PeersSector | |
---|---|---|---|---|
P/E Ratio | 8.2x | 17.9x | −0.5x | |
PEG Ratio | 0.01 | −0.37 | 0.00 | |
Price/Book | 0.5x | 1.2x | 2.6x | |
Price / LTM Sales | 0.6x | 1.3x | 3.0x | |
Upside (Analyst Target) | - | 29.1% | 54.7% | |
Fair Value Upside | Unlock | 13.6% | 8.4% | Unlock |